6307OX_PressRelease_29-02-16_5
- 1. FOR IMMEDIATE RELEASE • Monday 29th February 2016
Oxyless Ltd Receives FDA 510(K)
Clearance for New Blood Tubing Set
LONDON, UK. February 29, 2016 – Oxyless Ltd today announced that is
has received 510(k) clearance from the U.S. Food and Drug
Administration (FDA) for its new Blood Tubing set intended to provide
extracorporeal access to the patient’s blood during hemodialysis.
Oxyless Ltd
Oxyless Ltd is a UK based company that is committed to improving dialysis
patient outcomes and reducing the cost of dialysis treatments. Oxyless is
building close working relationships with nephrologists worldwide to highlight the
strengths of its Blood Tubing set, so that more dialysis patients can experience
the benefits.
www.oxyless.com
© Copyright 2016 Oxyless Ltd. All rights reserved